Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001396814-25-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-08 | 2025-09-04 | PCRX | Ceesay Abraham | Dir | S - Sale | $27.19 | -2,354 | 9,039 | -21% | -$64.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-04 | S | D | 2,354 | $27.19 | 9,039 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |